cell
potenti
control
infect
howev
limit
inform
avail
cell
epitop
function
antigen
specif
cell
infect
follow
immun
experiment
vaccin
peptid
panel
protein
select
silico
predict
bind
human
hlaa
mous
ld
dd
molecul
nine
previous
uncharacter
cell
epitop
identifi
infect
balbc
mice
specif
peptid
sequenc
stabil
hlaa
surfac
express
intermedi
high
affin
bind
peptid
specif
human
cell
line
peripher
blood
lymphocyt
gener
hlaa
donor
high
frequenc
peptid
specif
cell
respons
elicit
mice
dna
vaccin
demonstr
cell
mobil
vaccin
driven
cell
respons
display
focus
immun
respons
induc
viral
infect
furthermor
vaccin
reduc
viral
shed
reduc
clinic
impact
diseas
conclus
studi
describ
novel
epitop
elicit
strong
cell
respons
may
facilit
epitop
base
vaccin
design
aid
immunomonitor
antigen
specif
cell
frequenc
preclin
clinic
set
herp
simplex
viru
type
respons
recurr
genit
ulcer
cold
sore
herpet
stromal
kerat
fatal
enceph
contribut
morbid
seen
immunocompromis
individu
neonat
sever
infect
major
global
health
concern
estim
million
peopl
infect
subsaharan
africa
year
compar
million
us
million
europ
long
term
treatment
infect
antivir
drug
success
manag
diseas
reduc
recurr
activ
limit
viral
shed
reduc
transmiss
viru
although
therapeut
treatment
wide
avail
develop
prophylact
vaccin
achiev
steril
immun
highli
desir
two
clinic
vaccin
studi
aim
gener
neutral
antibodi
cell
respons
result
limit
success
former
prophylact
vaccin
deliv
glycoprotein
gd
gb
combin
adjuv
gener
neutral
antibodi
demonstr
transient
efficaci
minor
cohort
individu
anoth
prophylact
approach
use
glycoproteindsubunit
vaccin
alum
lipid
mpl
though
efficaci
observ
seroneg
femal
vaccin
strategi
aim
gener
cell
respons
target
addit
immunogen
protein
potenti
result
better
efficaci
increas
knowledg
cell
epitop
sequenc
aid
vaccin
design
incorpor
immunogen
peptid
sequenc
vaccin
allow
detail
phenotyp
analysi
character
kinet
cellular
immun
respons
immun
underli
mechanist
cell
control
well
understood
howev
emerg
data
highlight
import
cell
control
reactiv
maintain
establish
latenc
zhu
et
al
shown
cell
key
role
control
progress
local
site
infect
adopt
transfer
experi
use
ova
specif
cell
tkova
infect
mice
result
clearanc
infect
could
revers
vivo
neutral
interestingli
protein
recent
shown
target
granzym
b
mediat
degrad
result
non
lethal
viral
inactiv
cell
shown
control
viral
reactiv
cultur
trigemin
ganglia
tg
infect
mice
deplet
cell
cultur
promot
increas
rate
reactiv
clinic
studi
evalu
divers
restrict
cell
respons
protein
shown
greatest
frequenc
respons
direct
tegument
protein
found
patient
respons
broader
cell
respons
restrict
antigen
addit
respons
detect
ex
vivo
gd
protein
import
find
indic
tegument
protein
specif
cell
may
play
import
role
control
infect
provid
attract
opportun
immun
intervent
previous
shown
elicit
strong
cell
respons
mice
use
exploratori
vaccin
studi
limit
epitop
inform
avail
sought
identifi
epitop
sequenc
preclin
balbc
mous
model
use
combin
comput
predict
elispot
flow
cytometri
method
respons
also
demonstr
human
translat
studi
use
hlaa
bind
assay
human
cell
line
gener
peptid
driven
expans
well
conserv
epitop
sequenc
exhibit
function
activ
respons
cognat
peptid
stimul
vitro
order
induc
cell
respons
protein
activ
immun
construct
dna
vaccin
encod
full
length
protein
facilit
strong
mhc
class
mediat
express
viral
protein
dna
deliv
use
proprietari
gold
particl
mediat
epiderm
deliveri
pmed
tm
deliveri
devic
cell
respons
evalu
use
elispot
mobil
peptid
stimul
epitop
specif
cell
respons
gener
pmed
dna
immun
show
narrow
focus
cell
respons
toward
compar
infect
balbc
mice
cell
epitop
may
facilit
vaccin
design
aid
immunomonitor
peptid
specif
cell
respons
preclin
clinic
studi
comput
aid
epitop
identif
proven
power
tool
select
specif
area
within
larg
protein
sequenc
immunogen
potenti
aid
identif
restrict
cell
epitop
use
linear
base
epitop
detect
method
includ
elispot
narrow
peptid
specif
respons
peptid
vitro
cell
stimul
experi
use
balbc
mice
infect
peptid
deriv
identifi
base
abil
bind
kd
dd
ld
hlaa
mhc
molecul
use
immun
epitop
databas
tabl
sequenc
previous
shown
elicit
strong
cell
respons
preclin
experi
includ
posit
control
addit
flu
matrix
epitop
serv
posit
control
bioinformat
screen
stabil
studi
predict
perform
use
iedb
wwwimmuneepitopeorg
see
refer
method
b
known
binder
infect
studi
balbc
mice
perform
identifi
strong
peptid
specif
cell
respons
balbc
mice
infect
monitor
day
spleen
remov
harvest
splenocyt
elispot
use
measur
cell
respons
overnight
stimul
peptid
intravagin
infect
mice
strain
result
broad
detect
cellular
immun
respons
toward
figur
b
c
tabl
previous
report
mous
epitop
elicit
strong
respons
infect
n
expect
peptid
sequenc
previous
describ
also
posit
cell
respons
splenocyt
peptid
stimul
interestingli
overlap
amino
acid
sequenc
gave
lower
respons
figur
strong
peptid
specif
respons
seen
compar
publish
sequenc
figur
epitop
screen
peptid
result
three
strongli
posit
epitop
identifi
two
shown
figur
figur
splenocyt
puls
individu
peptid
naiv
mice
n
gave
background
respons
sfc
per
million
splenocyt
tabl
although
identif
potenti
epitop
mice
highli
inform
work
requir
assess
involv
cell
subset
abl
induc
product
made
use
peptid
span
amino
acid
natur
affin
mhc
class
molecul
howev
shown
mhc
class
ii
molecul
requir
sequenc
obtain
core
bind
exclud
possibl
mediat
respons
infect
cell
sort
cell
may
use
peptid
puls
studi
addit
measur
total
posit
respons
whole
viru
protein
full
set
overlap
peptid
span
full
length
viral
antigen
would
allow
rank
magnitud
peptid
specif
respons
predict
bind
valu
appar
balbc
allel
peptid
restrict
howev
experiment
valid
use
cell
line
express
molecul
requir
detail
preclin
mhcpeptid
tetramer
phenotyp
analysi
peptid
specif
cell
requir
identif
epitop
viral
protein
identifi
infect
set
viru
present
multipl
restrict
cell
epitop
differ
protein
translat
find
clinic
signific
necessari
determin
human
hlaa
restrict
epitop
protein
epitop
predict
highlight
potenti
peptid
bind
mhc
class
molecul
high
affin
affin
index
comparison
flu
matrix
epitop
cell
use
determin
affin
index
peptid
abl
bind
stabil
hlaa
mhc
molecul
figur
show
ai
peptid
calcul
mean
fluoresc
intens
four
peptid
sequenc
abl
reach
ai
high
affin
score
intermedi
affin
figur
figur
show
shift
intens
hlaa
cell
strongest
peptid
binder
human
donor
histori
infect
like
expos
align
hlaa
restrict
peptid
identifi
sequenc
protein
show
close
homolog
three
four
peptid
although
sampl
donor
requir
repetit
vitro
restimul
order
identifi
specif
respons
report
demonstr
specif
cell
seroneg
individu
similar
cell
found
expos
uninfect
individu
sequenc
conserv
amino
acid
ident
shown
tabl
report
describ
cell
respons
seroneg
individu
screen
hlaa
healthi
donor
establish
peptid
deriv
cell
line
repetit
peptid
puls
donor
figur
abl
identifi
peptid
specif
cell
respons
background
sd
figur
find
indic
presenc
small
frequenc
function
reactiv
peptid
specif
cell
abl
respond
peptid
stimul
ex
vivo
screen
phenotyp
cell
deriv
healthi
donor
posit
patient
use
peptidemhc
tetramer
complex
may
provid
addit
inform
frequenc
function
specif
cell
tabl
summar
epitop
identifi
studi
cours
present
studi
two
paper
publish
describ
peptid
select
preclin
efficaci
phase
clinic
trial
data
polyval
vaccin
consist
peptid
protein
studi
includ
singl
amino
acid
peptid
amino
acid
includ
peptid
aim
studi
gener
cellular
immun
describ
peptid
region
amino
acid
intermedi
affin
induc
reactiv
cell
natur
infect
tabl
also
describ
peptid
higher
affin
figur
stronger
respons
donor
tabl
appar
publish
preclin
studi
impact
peptid
vaccin
possibl
say
whether
altern
peptid
identifi
would
improv
efficaci
howev
import
futur
vaccin
design
abl
identifi
best
candid
peptid
drive
strong
immun
respons
provid
clinic
efficaci
full
length
dna
vaccin
encod
codon
optim
sequenc
construct
vaccin
deliveri
use
pmed
devic
dna
vaccin
deliveri
use
pmed
gene
gun
demonstr
success
clinic
provid
safe
altern
approach
needl
base
intramuscular
deliveri
requir
milligram
dna
gold
particl
contain
dna
given
singl
actuat
shave
abdomen
balbc
mice
without
adjuv
mice
given
second
booster
vaccin
day
primari
immun
spleen
remov
day
assess
cell
respons
use
elispot
mobil
peptid
stimul
figur
ag
tabl
tabl
show
peptid
specif
elispot
respons
dna
vaccin
protein
strong
specif
respons
observ
previous
unidentifi
epitop
sfcmillion
pbl
strongest
respons
restrict
epitop
sfcmillion
pbl
interestingli
cell
respons
seen
epitop
elicit
specif
cell
infect
find
suggest
vaccin
driven
respons
gener
cell
immunodomin
sequenc
mobil
show
broad
degranul
peptid
specif
cell
frequenc
excess
background
level
figur
e
f
interestingli
posit
respons
seen
epitop
dna
immun
contrast
includ
irrelev
peptid
background
subtract
total
cell
degranul
peptid
stimul
respect
figur
c
collect
data
illustr
potenti
immunodomin
broad
function
cytokin
secret
cell
rais
dna
immun
similarli
like
strong
cell
respons
observ
epitop
infect
cell
degranul
respons
peptid
stimul
dna
immun
present
modest
frequenc
total
cell
specif
cellular
respons
gener
infect
dna
vaccin
vaccin
mice
challeng
investig
potenti
respons
protect
infect
intravagin
intranas
challeng
model
vaccin
mice
provid
protect
viral
shed
intravagin
model
five
eight
anim
shed
viru
either
one
four
day
post
infect
compar
three
eight
control
figur
mean
viral
titer
vaccin
unvaccin
group
day
four
postinfect
respect
vaccin
mice
demonstr
trend
toward
lower
clinic
score
unvaccin
counterpart
although
demonstr
signific
figur
vaccin
protect
intranas
challeng
model
vaccin
mice
show
reduc
clinic
score
delay
onset
signific
diseas
figur
cell
control
establish
latenc
infect
fulli
understood
addit
work
use
cell
line
clone
sort
patient
transwel
migrat
experi
may
allow
better
understand
therapeut
approach
control
elimin
infect
cell
cell
recruit
site
infect
recent
shown
depend
heavili
upon
cell
induc
mobil
gradient
import
find
suggest
vaccin
design
induc
cell
cell
help
live
imag
techniqu
use
antigen
specif
cell
adopt
transfer
experi
rag
knockout
mice
would
provid
valuabl
data
local
cell
subsequ
mode
action
shown
vaccinia
viru
rout
infect
may
skew
peptid
specif
respons
certain
epitop
enhanc
diminish
domin
cell
respons
studi
assess
intraocular
rout
infect
furthermor
ration
singl
amino
acid
modif
peptid
known
elicit
stimulatori
respons
may
enhanc
immunogen
therefor
result
favor
outcom
epitop
base
vaccin
diseas
challeng
set
dna
vaccin
deliv
use
pmed
devic
elicit
strong
cell
peptid
stimul
interest
note
peptid
specif
cell
frequenc
could
compar
cell
posit
express
elispot
peptid
stimul
furthermor
balbc
mice
infect
show
greater
frequenc
cell
specif
epitop
mice
immun
dna
vaccin
tabl
import
note
mice
infect
also
display
greater
coverag
epitop
specif
respons
dna
vaccin
skew
specif
respons
epitop
due
polyfunct
natur
cell
gener
vaccin
work
requir
dissect
proport
pentamertetram
specif
cell
capabl
mount
respons
translat
experi
use
hlaa
restrict
epitop
describ
studi
hlaa
infect
transgen
mice
seroposit
donor
may
provid
clearer
understand
frequenc
function
restrict
cell
ex
vivo
addit
vaccin
develop
translat
experi
use
vitro
dc
cell
cocultur
experi
would
provid
clearer
understand
immunogen
function
hla
restrict
epitop
initi
screen
respons
peptid
perform
peptid
overlap
amino
acid
deriv
access
number
version
gi
gi
gi
data
shown
peptid
synthes
sigmaaldrich
corp
st
loui
mo
sequenc
found
give
posit
respons
select
subsequ
fine
map
character
peptid
select
restrict
peptid
span
amino
acid
perform
mous
mhc
class
molecul
human
hlaa
use
immun
epitop
databas
iedb
total
peptid
select
theoret
valu
rang
nm
span
select
region
protein
shown
tabl
overlap
amino
acid
sequenc
differ
valu
span
sequenc
includ
assess
impact
residu
modif
extent
immunogen
peptid
amino
acid
length
synthes
puriti
epitop
map
sigmaaldrich
total
peptid
obtain
dissolv
dmso
sigma
stock
concentr
mgml
peptid
use
final
concentr
unless
otherwis
state
peptid
stabil
studi
well
defin
hlaa
sequenc
influenza
matrix
protein
gilgfvftl
use
posit
control
anaspec
ca
us
six
eight
week
old
femal
balbc
mice
charl
river
uk
use
studi
experi
carri
complianc
uk
legisl
subject
local
ethic
review
human
endpoint
strictli
adher
six
day
prior
infect
mice
given
depo
provera
medroxyprogesteron
pfizer
ltd
subcutan
ensur
mice
enter
diestru
infect
day
mice
n
infect
pfu
strain
total
volum
pb
intravagin
administr
control
group
n
given
pb
intravagin
rout
day
postinfect
vagin
lavag
collect
pipet
phosphat
buffer
salin
vagina
sever
time
transfer
vial
store
assay
viral
load
use
plaqu
assay
mice
monitor
day
health
check
daili
use
clinic
score
system
record
bodi
weight
patholog
assess
use
score
follow
healthi
appar
infect
slight
red
red
swell
sever
red
surround
area
ulcer
andor
hairloss
score
addit
addit
clinic
sign
procedur
carri
author
uk
home
offic
project
licens
accord
uk
government
regul
anim
scientif
procedur
act
group
eight
ten
mice
lightli
anesthet
gener
anesthesia
isofluran
pfu
strain
slowli
pipet
onto
tip
nose
mice
kept
back
complet
recoveri
anesthesia
follow
infect
mice
weigh
score
daili
oper
blind
ident
treatment
group
use
follow
clinic
score
appar
infect
piloerect
andor
breath
difficulti
reduc
movementdul
squint
eye
sore
eye
ocular
discharg
andor
hunch
symptom
sever
respir
difficulti
paralysi
mous
approach
score
sacrif
vero
cell
grown
confluenc
well
plate
sampl
dilut
emem
medium
ad
confluent
monolay
follow
one
hour
incub
period
inoculum
remov
ml
overlay
carboxymethyl
cellulos
solut
ad
incub
anoth
day
one
hour
prior
read
plate
ml
neutral
red
solut
ad
enhanc
visibl
plaqu
splenocyt
infect
mice
harvest
mechan
disrupt
wash
twice
serum
free
cell
cultur
media
splenocyt
resuspend
plate
dilut
pb
fc
mabtech
sweden
coat
pvdf
polyvinyliden
difluorid
back
micropl
millipor
concentr
cellswel
prior
addit
splenocyt
pvdf
plate
wash
block
fc
sigma
h
individu
peptid
final
concentr
ad
well
cultur
hr
humid
co
incub
next
day
plate
develop
use
manufactur
instruct
mabtech
sweden
spot
read
count
autom
elispot
counter
aid
diagnostika
gmbh
result
express
spot
form
cell
sfc
per
cell
standard
error
mean
sem
respons
equal
greater
sfc
per
million
splenocyt
consid
posit
respons
mutant
hybrid
cell
line
deriv
tlymphoblast
cell
line
cem
obtain
atcc
cell
lack
function
transport
associ
antigen
process
tap
heterodim
fail
express
normal
amount
hlaa
cell
surfac
hlaa
surfac
express
stabil
exogen
load
peptid
abl
bind
mhc
class
molecul
cell
line
maintain
rpmi
sigmaaldrich
supplement
heatinactiv
fetal
calf
serum
fc
u
penicillinml
u
streptomycinml
collect
call
sigmaaldrich
cell
degranul
shown
prerequisit
perforin
granzym
mediat
cell
lysi
degranul
measur
mobil
lysosom
membran
compart
cell
surfac
result
increas
cell
surfac
express
briefli
mix
splenocyt
transfer
v
bottom
fac
plate
bd
media
medium
stimul
peptid
presenc
bd
pharmingen
hour
cona
sigma
irrelev
peptid
use
posit
neg
control
respect
cell
wash
stain
antibodi
bd
pharmingen
cell
wash
fix
use
cytofix
solut
bd
bioscienc
accord
manufactur
instruct
minimum
cell
acquir
fac
canto
ii
use
ht
modul
bd
bioscienc
analysi
perform
use
fac
diva
frequenc
present
percentag
posit
cell
total
cell
irrelev
control
frequenc
subtract
cell
cultur
media
co
peptid
test
abil
bind
stabil
hlaa
molecul
surfac
cell
cell
suspend
media
distribut
plate
bd
cell
incub
peptid
final
concentr
media
also
supplement
microglobulin
sigma
h
cell
stain
antihlaa
monoclon
antibodi
bd
pharmingen
analyz
minut
ice
number
stabil
hlaa
molecul
surfac
cell
determin
fluoresc
intens
abil
peptid
combin
hlaa
calcul
follow
ai
mfi
mfi
mfi
mfi
ai
affin
index
hlaa
mfi
mean
fluoresc
index
mfi
stain
cell
treat
peptid
mfi
mfi
stain
cell
without
peptid
treatment
mfi
mfi
cell
stain
isotyp
control
antibodi
ai
peptid
score
equal
greater
display
high
affin
intermedi
affin
regard
low
affin
peptid
previous
describ
peptid
specif
cell
gener
healthi
donor
use
peptid
display
intermedi
high
affin
bind
cell
obtain
peptid
specif
cell
pbl
taken
healthi
donor
hlaa
posit
process
describ
previous
pbl
donor
lymphocyt
puls
everi
day
select
peptid
presenc
imdm
human
serum
sigma
unitsml
r
system
cell
respond
peptid
later
maintain
ngml
r
system
minneapoli
mn
allow
low
level
prolifer
surviv
pbl
deriv
hlaa
donor
stimul
peptid
stimul
perform
one
hour
puls
peptid
ng
prior
growth
seven
day
elispot
perform
stimul
monitor
progress
stimul
cell
assess
peptid
specif
respons
overnight
elispot
assay
elispot
perform
describ
use
mabtech
human
elispot
kit
mabtech
sweden
dna
vaccin
construct
formul
onto
gold
particl
pmed
deliveri
use
method
previous
describ
briefli
codon
optim
cdna
sequenc
synthes
geneart
ag
regensburg
germani
subclon
plasmid
respect
recombin
mrna
express
confirm
vector
rtpcr
follow
transfect
cho
cell
monoval
dna
vaccin
plasmid
precipit
onto
gold
bead
rang
diamet
fill
cassett
helium
acceler
dnagold
particl
deliveri
singl
use
devic
actuat
devic
formul
deliv
dna
mg
gold
balbc
mice
n
week
old
intraderm
immun
singl
actuat
devic
encod
dna
construct
gold
immun
procedur
carri
author
uk
home
offic
project
licens
use
linear
base
epitop
detect
method
character
sever
potenti
cell
epitop
protein
infect
model
balbc
mice
experiment
valid
perform
use
infect
mous
model
result
compar
respons
elicit
dna
encod
vaccin
respons
shown
elispot
gener
higher
magnitud
infect
model
vaccin
anim
epitop
could
use
monitor
peptid
specif
cell
respons
dna
vaccin
deliveri
antigen
possibl
optim
vaccin
strategi
may
gener
suffici
strong
broad
respons
mimic
respons
seen
infect
anim
